Semaglutide for Blood Sugar and Weight in Diverse Diabetes Populations

Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms consistent efficacy across different patient demographics.

Alzahrani, Mahmoud et al.·Cureus·2025·Moderate Evidencecohort
RPEP-09918CohortModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
cohort
Evidence
Moderate Evidence
Sample
N=medium
Participants
238 adults with type 2 diabetes in primary care in Jeddah, Saudi Arabia

What This Study Found

Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms consistent efficacy across different patient demographics.

Key Numbers

238 patients studied. Electronic health record data from a primary care clinic in Jeddah, Saudi Arabia.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide therapeutic knowledge.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting.
Published In:
Cureus, 17(4), e82123 (2025)
Database ID:
RPEP-09918

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What does this mean?

Study of semaglutide effects on glycemic control and body weight in diverse T2D populations confirms consistent efficacy across different patient demographics.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09918·https://rethinkpeptides.com/research/RPEP-09918

APA

Alzahrani, Mahmoud; Rammal, Lama; Felemban, Razaz; Khan, Muhammed; Saad, Hamza; Alrezqi, Muhammed; Alsulami, Nabil; Alabdullatif, Abdulelah; Alawashiz, Zyad. (2025). Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting.. Cureus, 17(4), e82123. https://doi.org/10.7759/cureus.82123

MLA

Alzahrani, Mahmoud, et al. "Effects of Semaglutide on Glycemic Control and Body Weight in Patients With Type 2 Diabetes: A Retrospective Cohort Study in a Primary Care Setting.." Cureus, 2025. https://doi.org/10.7759/cureus.82123

RethinkPeptides

RethinkPeptides Research Database. "Effects of Semaglutide on Glycemic Control and Body Weight i..." RPEP-09918. Retrieved from https://rethinkpeptides.com/research/alzahrani-2025-effects-of-semaglutide-on

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.